Search results
Factor V Deficient Plasma
Measurement of factor V (FV / proaccelerin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FV deficient plasma is required
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
ZYMUTEST TAFI (Activatable)
Assay proposed for the measurement of TAFI in research applications.
ZYMUTEST TAFI (Total) Antigen
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.
Antithrombin EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
Thrombin-Heparin Cofactor II Complex EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
Heparin Control, CRYOcheck (frozen)
Abnormal control for activated partial thromboplastin time (aPTT) assays.
Fibrinogen Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human fibrinogen deficient plasma is required.
Factor XIII Deficient Plasma
For any in vitro protocol or research study where a source of human FXIII deficient plasma is required.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.